2023 COPD Guidelines Update

Antonio Anzueto

COPD Exacerbations: if Not, What Else?

Temple Lung Center

J. Bon

Updates in Pulmonary Function Testing

National Jewish Health

M. Mohning

COPD Classification and Practical Management Strategies

PulmPEEPs

D. Furfaro, K. Montemayor, R. A Wise, W. Labaki

Bronchiectasis: What's New and What's Next?

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

S. Devarajan

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

Alpha One - Antitrypsin Deficiency: More Common Than You Think

Kyle Hogarth

Short Course Antibiotic Therapy

McMaster University Department of Medicine

B. Spellberg

Updates in Chronic Obstructive Pulmonary Disease

Duke Health

Z. Hager

GOLD 2023 Update: Implications for Clinical Practice

Jill Ohar

Inhaler Selection in COPD

CHEST 2022 Coverage

D. Mahler

ATS 2022: Before We Can Run - Racial Health Disparities in Lung Dise…

Aaron Baugh

COPD: Dual Vs. Triple Therapy

Stephen Brunton

Chronic Cough, Refractory Cough, Cough Hypersensitivity Syndrome and…

National Jewish Health

R. Balkissoon

Access to Diagnostics and Medicines for COPD in Low or Middle-Income…

Temple Lung Center

O. Beatrice Ozoh

Management of Chronic Respiratory Failure With Non-Invasive Ventilat…

Michigan Medicine

P. Choi

COPD: Current and Emerging Management Strategies

Brigham and Women's Hospital

C. P. Hersh

Myocardial Viability Testing and Coronary Revascularization in Ische…

37th Annual Advances in Heart Disease

J. MacGregor, P. Ganz

LAMA, LABA, ICS, PDE4i, Triple, Dual, Double: Unraveling the Pharmac…

Temple Lung Center

M. Dransfield

Therapeutic Options for Acute COPD Exacerbations: GOLD 2024 Guidelin…

Sami Hossri